TECHNOLOGY

ACCEL ELISA    Technologies

​®

ADVANTAGES OF ACCEL ELISA®

Stationary Homogeneous Immunoassay Platform Technology with Maximized Speed

Antibody Screening

Conventional

VS

ACCEL ELISA®

7.8 - 50.0 ng/ml

120min.

0.39 - 25.0 ng/ml

30min.

Detection Range

Speed

Biomarker Screening

Conventional

VS

ACCEL ELISA®

0.78 - 5 ng/ml

240 min.

0.27 - 1.6 ng/ml

20 min.

Detection Range

Speed

Cortisol Screening

Conventional

VS

ACCEL ELISA®

0.15 - 10 ng/ml

180 min.

0.15 - 5.0 ng/ml

20 min.

Detection Range

Speed

Disease Screening

Conventional

VS

ACCEL ELISA®

1.0 - 65 ng/ml

90 min.

0.2 - 50 ng/ml

20 min.

Detection Range

Speed

TECHNOLOGY

Stationary Homogeneous Immunoassay

Platform Technology with Maximized Speed

Surface treatment

technology

Plexense’s proprietary surface chemistry eliminates blocking steps.

Proprietary design of

plate and wells

Increased surface area offers higher

sensitivity and improved enzymatic

reaction rates.

Proprietary reagent

formulation

Customized reagents simplifies

complicated reaction steps into

two reaction steps with one wash.

info@plexense.com |#B-604, 670, Daewangpangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, Republic of Korea 13494

COPYRIGHTⓒ 2020 PLEXENSE, INC. ALL RIGHTS RESERVED

Information contained in this website is for a wide range of audiences and may contain product details or information not accessible or valid in your country. Please note that we do not take any responsibility for accessing information that does not comply with any legal process, regulation, registration or usage in your country.